Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Colorectal Neoplasms and CYP3A5[original query] |
|---|
| Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. BMC cancer 2007 7 (1): 123. Bethke Lara, Webb Emily, Sellick Gabrielle, Rudd Matthew, Penegar Stephen, Withey Laura, Qureshi Mobshra, Houlston Richa |
| Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients. BMC cancer 2007 7 (1): 118. Gervasini Guillermo, García-Martín Elena, Ladero José M, Pizarro Rosa, Sastre Javier, Martínez Carmen, García Monserrat, Diaz-Rubio Manuel, Agúndez José A |
| UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan. Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Jun 13 (11): 3269-75. Côté Jean-François, Kirzin Sylvain, Kramar Andrew, Mosnier Jean-François, Diebold Marie-Danièle, Soubeyran Isabelle, Thirouard Anne-Sophie, Selves Janick, Laurent-Puig Pierre, Ychou Ma |
| Genotyping of CYP3A5 polymorphisms among Bulgarian patients with sporadic colorectal cancer and controls. Onkologie 2007 Nov 30 (11): 559-63. Petrova Darinka Todorova, Yaramov Nikolay, Toshev Svetoslav, Nedeva Petya, Maslyankov Svilen, von Ahsen Nicolas, Oellerich Michael, Toncheva Dra |
| Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Jul 28 (20): 3227-33. McLeod Howard L, Sargent Daniel J, Marsh Sharon, Green Erin M, King Cristi R, Fuchs Charles S, Ramanathan Ramesh K, Williamson Stephen K, Findlay Brian P, Thibodeau Stephen N, Grothey Axel, Morton Roscoe F, Goldberg Richard |
| CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Aug 34 (4): 2357-66. Wang Bao-Sheng, Liu Zhen, Xu Wei-Xue, Sun Shao-Lo |
| Genetic polymorphisms in cytochrome P450 and clinical outcomes of FOLFIRI chemotherapy in patients with metastatic colorectal cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 May . Dong Ningning, Meng Fandong, Wu Yongdong, Wang Mingyu, Cui Yongchun, Zhang Shuti |
| Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L. Frontiers in pharmacology 2017 8 712. Labriet Adrien, De Mattia Elena, Cecchin Erika, Lévesque Éric, Jonker Derek, Couture Félix, Buonadonna Angela, D'Andrea Mario, Villeneuve Lyne, Toffoli Giuseppe, Guillemette Chant |
| Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy. Scientific reports 2020 Aug 10 (1): 13486. Atasilp Chalirmporn, Chansriwong Phichai, Sirachainan Ekaphop, Reungwetwattana Thanyanan, Sirilerttrakul Suwannee, Chamnanphon Monpat, Puangpetch Apichaya, Sukasem Chonlaph |
| Is OPRM1 genotype a valuable predictor of VAS in patients undergoing laparoscopic radical resection of colorectal cancer with fentanyl? BMC anesthesiology 2023 5 23 (1): 173. Yan Zhou, Lei Cao, Yihui Yang, Yaoyi Gao, Yihao Li, Beili Wang, Baishen Pan, Jian Huang, Wei G |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: